Friday, October 24, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

BMO Capital Analyst Reaffirms Republic Services with Market Perform Rating and Raises Price Target

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Finance_Financialization
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

BMO Capital analyst Devin Dodge has reaffirmed Republic Services (NYSE:RSG) with a Market Perform rating and raised the price target to $195 on February 28, 2024. This adjustment signifies a bullish outlook on the company’s future performance. The decision to uphold the Market Perform rating indicates a neutral position on the stock’s potential compared to the market average.

This latest update from BMO Capital is in line with their previous analysis, highlighting Republic Services’ steady growth and promising prospects. The increased price target reflects confidence in the company’s ability to generate value for investors. Other analysts, like Goldman Sachs, have also upped their price targets for Republic Services, signaling optimism about the company’s future in the market.

In summary, BMO Capital’s decision to maintain a Market Perform rating while raising the price target for Republic Services showcases a well-rounded perspective on the stock’s performance and growth potential in the market.

RSG Stock Shows Resilience and Strength on February 28, 2024

On February 28, 2024, RSG stock exhibited strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of RSG shares closed at $184.52 on this day, representing a decrease of $0.35 or 0.19% since the market last closed. Despite this slight drop, the stock showed resilience in after-hours trading, rising by $2.58. Overall, RSG’s performance on February 28, 2024, demonstrates its strength and stability in the market. Investors may want to keep an eye on RSG as it continues to show positive momentum and potential for further growth.

RSG Stock Performance Analysis: Total Revenue and Net Income Growth in 2024

On February 28, 2024, investors and analysts closely watched the performance of RSG stock following the release of the company’s financial data. According to CNN Money, RSG reported total revenue of $14.96 billion for the past year, with a fourth-quarter revenue of $3.83 billion.

Net income for RSG was reported at $1.73 billion for the past year, with a fourth-quarter net income of $439.60 million.

Earnings per share (EPS) for RSG were $5.47 for the past year, with a fourth-quarter EPS of $1.39.

Overall, the financial performance of RSG on February 28, 2024, showed positive growth in total revenue and net income compared to the previous year. However, the decrease in net income and EPS from the previous quarter may have raised some concerns among investors. It will be interesting to see how RSG stock performs in the coming days as investors digest this financial data and assess the company’s future prospects.

Tags: RSG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Fiscal (3)

JP Morgan Analyst Upgrades Axon Enterprise to Overweight with 330 Price Target

Revolutionary Weight Loss Implants by Vivani Medical A GameChanger in Obesity Treatment

Finance_Investment (2)

Analyst Upgrades Carlyle Secured Lending to Neutral Rating and Raises Price Target

Recommended

Finance_ Chart up

Options Market Activity and Sentiment Shift for Goldman Sachs Group Inc

2 years ago
Eastman Kodak Stock

Eastman Kodak’s Financial Future Hangs in the Balance

2 months ago
Finance_Fiscal (3)

Mastercard Revolutionizes B2B Healthcare Payments with Virtual Cards

2 years ago
Renewable energy

Corbus Pharmaceuticals Holdings Unprecedented Surge and Trading Halt

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Bitcoin’s Calm Consolidation Masks Significant Accumulation

Cellectar Biosciences at a Critical Juncture: Regulatory and Financial Developments Converge

Super Micro Stock Plummets After Stunning Forecast Downgrade

3M Shares Surge on Strong Quarterly Performance and Upbeat Forecast

High-Yield Gamble: The Oxford Square Capital Investment Dilemma

Freddie Mac Investors Face Critical Juncture Amid Conflicting Forces

Trending

Novo Nordisk Stock
European Markets

Leadership Shakeup at Novo Nordisk Sparks Investor Uncertainty

by Dieter Jaworski
October 24, 2025
0

Novo Nordisk finds itself navigating turbulent waters as a sweeping leadership overhaul creates uncertainty for shareholders. The...

CureVac Stock

CureVac Acquisition Enters Final Phase as BioNTech Makes Formal Bid

October 24, 2025
Puma Stock

Can Puma’s Radical Overhaul Reverse Its Downward Spiral?

October 24, 2025
Bitcoin Stock

Bitcoin’s Calm Consolidation Masks Significant Accumulation

October 24, 2025
Cellectar Biosciences Stock

Cellectar Biosciences at a Critical Juncture: Regulatory and Financial Developments Converge

October 24, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Leadership Shakeup at Novo Nordisk Sparks Investor Uncertainty
  • CureVac Acquisition Enters Final Phase as BioNTech Makes Formal Bid
  • Can Puma’s Radical Overhaul Reverse Its Downward Spiral?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com